Research Article| Volume 378, P153-157, July 15, 2017

Download started.


Usefulness of the superior cerebellar peduncle for differential diagnosis of progressive supranuclear palsy: A meta-analysis


      • The usefulness of SCP in diagnosis of PSP was assessed by a meta-analysis.
      • Age and HY stage contributed to SMD in size between PSP and PD.
      • PSP showed more reduced size of SCP than MSA with homogeneous studies.
      • There was no significant difference in ADC between groups including PSP, PD or MSA.


      Previous studies have reported the usefulness of superior cerebellar peduncle (SCP) abnormalities in diagnosing progressive supranuclear palsy. However, the results of these studies were heterogeneous. In the present meta-analysis, we aimed to establish more robust evidence of SCP abnormalities in progressive supranuclear palsy, and to determine the cause of the previously reported heterogeneity. We identified six studies on SCP size and three studies on apparent diffusion coefficient. Key features of each study were extracted and standardized differences in size and apparent diffusion coefficient values were calculated. There was some heterogeneity in terms of the reduction in SCP size in patients with progressive supranuclear palsy compared to those with Parkinson's disease. Moreover, age and Hoehn-Yahr stage negatively correlated with standardized mean difference in SCP size between patients with progressive supranuclear palsy and Parkinson's disease. There was homogenous agreement that the SCP was smaller in patients with progressive supranuclear palsy compared to those with multiple system atrophy. Finally, in terms of apparent diffusion coefficient, there was no significant difference between patients with progressive supranuclear palsy, Parkinson's disease, or multiple system atrophy. Together, these findings suggest that SCP size, when corrected for age and disease severity, could be a diagnostic tool for progressive supranuclear palsy.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of the Neurological Sciences
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Richardson J.C.
        • Steele J.
        • Olszewski J.
        Supranuclear ophthalmoplegia, pseurobulbar palsy, nuchal dystonia and dementia. A clinical report on eight cases of "heterogenous system degeneration".
        Trans. Am. Neurol. Assoc. 1963; 88: 25-29
        • Dickson D.W.
        Parkinson's disease and parkinsonism: neuropathology.
        Cold Spring Harb. Perspect. Med. 2012; 2: a009258
        • Williams D.R.
        • Lees A.J.
        What features improve the accuracy of the clinical diagnosis of progressive supranuclear palsy-parkinsonism (PSP-P)?.
        Mov. Disord. 2010; 25: 357-362
        • Warmuth-Metz M.
        • Naumann M.
        • Csoti I.
        • Solymosi L.
        Measurement of the midbrain diameter on routine magnetic resonance imaging: a simple and accurate method of differentiating between Parkinson disease and progressive supranuclear palsy.
        Arch. Neurol. 2001; 58: 1076-1079
        • Oba H.
        • Yagishita A.
        • Terada H.
        • Barkovich A.J.
        • Kutomi K.
        • Yamauchi T.
        • et al.
        New and reliable MRI diagnosis for progressive supranuclear palsy.
        Neurology. 2005; 64: 2050-2055
        • Paviour D.C.
        • Price S.L.
        • Jahanshahi M.
        • Lees A.J.
        • Fox N.C.
        Regional brain volumes distinguish PSP, MSA-P, and PD: MRI-based clinico-radiological correlations.
        Mov. Disord. 2006; 21: 989-996
        • Paviour D.C.
        • Thornton J.S.
        • Lees A.J.
        • Jager H.R.
        Diffusion-weighted magnetic resonance imaging differentiates Parkinsonian variant of multiple-system atrophy from progressive supranuclear palsy.
        Mov. Disord. 2007; 22: 68-74
        • Nicoletti G.
        • Tonon C.
        • Lodi R.
        • Condino F.
        • Manners D.
        • Malucelli E.
        • et al.
        Apparent diffusion coefficient of the superior cerebellar peduncle differentiates progressive supranuclear palsy from Parkinson's disease.
        Mov. Disord. 2008; 23: 2370-2376
        • Quattrone A.
        • Nicoletti G.
        • Messina D.
        • Fera F.
        • Condino F.
        • Pugliese P.
        • et al.
        MR imaging index for differentiation of progressive supranuclear palsy from Parkinson disease and the Parkinson variant of multiple system atrophy.
        Radiology. 2008; 246: 214-221
        • Gama R.L.
        • Tavora D.G.
        • Bomfim R.C.
        • Silva C.E.
        • de Bruin V.M.
        • de Bruin P.F.
        Sleep disturbances and brain MRI morphometry in Parkinson's disease, multiple system atrophy and progressive supranuclear palsy - a comparative study.
        Parkinsonism Relat. Disord. 2010; 16: 275-279
        • Choi S.M.
        • Kim B.C.
        • Nam T.S.
        • Kim J.T.
        • Lee S.H.
        • Park M.S.
        • et al.
        Midbrain atrophy in vascular Parkinsonism.
        Eur. Neurol. 2011; 65: 296-301
        • Longoni G.
        • Agosta F.
        • Kostic V.S.
        • Stojkovic T.
        • Pagani E.
        • Stosic-Opincal T.
        • et al.
        MRI measurements of brainstem structures in patients with Richardson's syndrome, progressive supranuclear palsy-parkinsonism, and Parkinson's disease.
        Mov. Disord. 2011; 26: 247-255
        • Morelli M.
        • Arabia G.
        • Salsone M.
        • Novellino F.
        • Giofre L.
        • Paletta R.
        • et al.
        Accuracy of magnetic resonance parkinsonism index for differentiation of progressive supranuclear palsy from probable or possible Parkinson disease.
        Mov. Disord. 2011; 26: 527-533
        • Tsukamoto K.
        • Matsusue E.
        • Kanasaki Y.
        • Kakite S.
        • Fujii S.
        • Kaminou T.
        • et al.
        Significance of apparent diffusion coefficient measurement for the differential diagnosis of multiple system atrophy, progressive supranuclear palsy, and Parkinson's disease: evaluation by 3.0-T MR imaging.
        Neuroradiology. 2012; 54: 947-955
        • Massey L.A.
        • Jager H.R.
        • Paviour D.C.
        • O'Sullivan S.S.
        • Ling H.
        • Williams D.R.
        • et al.
        The midbrain to pons ratio: a simple and specific MRI sign of progressive supranuclear palsy.
        Neurology. 2013; 80: 1856-1861
        • Hara K.
        • Watanabe H.
        • Ito M.
        • Tsuboi T.
        • Watanabe H.
        • Nakamura R.
        • et al.
        Potential of a new MRI for visualizing cerebellar involvement in progressive supranuclear palsy.
        Parkinsonism Relat. Disord. 2014; 20: 157-161
        • Morelli M.
        • Arabia G.
        • Messina D.
        • Vescio B.
        • Salsone M.
        • Chiriaco C.
        • et al.
        Effect of aging on magnetic resonance measures differentiating progressive supranuclear palsy from Parkinson's disease.
        Mov. Disord. 2014; 29: 488-495
        • Sako W.
        • Murakami N.
        • Izumi Y.
        • Kaji R.
        The difference in putamen volume between MSA and PD: evidence from a meta-analysis.
        Parkinsonism Relat. Disord. 2014; 20: 873-877
        • Sako W.
        • Murakami N.
        • Miyazaki Y.
        • Abe T.
        • Harada M.
        • Izumi Y.
        • et al.
        The effect of tremor onset on middle cerebellar peduncle of Parkinson's disease.
        J. Neurol. Sci. 2015; 358: 172-177
        • Sako W.
        • Murakami N.
        • Izumi Y.
        • Kaji R.
        Neurofilament light chain level in cerebrospinal fluid can differentiate Parkinson's disease from atypical parkinsonism: evidence from a meta-analysis.
        J. Neurol. Sci. 2015; 352: 84-87
        • Sako W.
        • Murakami N.
        • Izumi Y.
        • Kaji R.
        The difference of apparent diffusion coefficient in the middle cerebellar peduncle among parkinsonian syndromes: evidence from a meta-analysis.
        J. Neurol. Sci. 2016; 363: 90-94
        • Sako W.
        • Miyazaki Y.
        • Izumi Y.
        • Kaji R.
        Which target is best for patients with Parkinson's disease? A meta-analysis of pallidal and subthalamic stimulation.
        J. Neurol. Neurosurg. Psychiatry. 2014; 85: 982-986
        • Egger M.
        • Davey Smith G.
        • Schneider M.
        • Minder C.
        Bias in meta-analysis detected by a simple, graphical test.
        BMJ. 1997; 315: 629-634
        • Tsuboi Y.
        • Slowinski J.
        • Josephs K.A.
        • Honer W.G.
        • Wszolek Z.K.
        • Dickson D.W.
        Atrophy of superior cerebellar peduncle in progressive supranuclear palsy.
        Neurology. 2003; 60: 1766-1769
        • Sako W.
        • Murakami N.
        • Izumi Y.
        • Kaji R.
        Reduced alpha-synuclein in cerebrospinal fluid in synucleinopathies: evidence from a meta-analysis.
        Mov. Disord. 2014; 29: 1599-1605